Position in TAK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$350,509
-$209,646 QoQ
Shares Held
18,926
-44.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TAK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AXQ CAPITAL, LP holds $3,343,099 across 12 Drug Manufacturers - Specialty & Generic names. TAK ranks #4 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
70,622 | $954,103 | |
| 2 | COLL |
Collegium Pharmaceutical, Inc
|
17,976 | $594,466 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
38,952 | $370,823 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
This page
|
18,926 | $350,509 | |
| 5 | ESPR |
Esperion Therapeutics, Inc.
|
94,159 | $257,995 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
47,968 | $199,067 | |
| 7 | EOLS |
Evolus, Inc.
|
47,670 | $195,923 | |
| 8 | EBS |
Emergent BioSolutions Inc.
|
17,004 | $141,133 |
All Filings in TAK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $350,509 | 18,926 | Shares | Sole | 2026-05-13 | |
| 2023-03-31 | $560,155 | 33,990 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||